Shanghai Chengzhi Biotechnology Inc., provides a stable expression cell line of cas9 nuclease. These cell lines can provide a convenient and efficient tool for your CRISPR genome editing application. The combination of cas9 nuclease and sgRNAs has been widely used in eukaryotic cells and animal models to generate targeted genomic modifications, including gene knockout, mutation modification, endogenous gene fusion tags and many other applications.